⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,692.59
+0.43%
Nasdaq 100
29,538.41
+1.20%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.15
+1.41%
NYSE:TSM
$420.27
+1.86%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,140.75
−0.59%
Brent
$109.32
−0.45%
BTC
$81,803.72
−0.26%
ETH
$2,394.06
−0.55%
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,692.59
+0.43%
Nasdaq 100
29,538.41
+1.20%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.15
+1.41%
NYSE:TSM
$420.27
+1.86%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,140.75
−0.59%
Brent
$109.32
−0.45%
BTC
$81,803.72
−0.26%
ETH
$2,394.06
−0.55%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Cipla Ltd · News · TradingHolo
Markets
›
India
› NSE
› CIPLA
C
Cipla Ltd
NSE:CIPLA
Healthcare
NSE:CNX100
NSE:CNX200
—
—
At close · Market cap
—
· Next earnings
Tue 27 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
News
Profile
CIPLA news
Headlines tagged to this company
MO
Q2 preview: Domestic demand to lift pharma sales but US pricing pressure likely weighs on earnings
Moneycontrol · 4 d ago
MO
Trade Spotlight: How should you trade Gabriel India, Dr Reddys Labs, MCX India, Craftsman Automation, Solar Industries, and others on October 13?
Moneycontrol · 7 d ago
MI
TCS, HDFC Life, Cipla - Which stock to buy and sell? Jigar Patel of Anand Rathi suggests strategy - Target, stop loss
Mint · 8 d ago
RE
Global healthcare companies invest billions to boost US presence
Reuters · 13 d ago
BU
Gaurav Kaul Takes Charge As MD And CEO Of Cipla Health
Businessworld · 14 d ago
CN
These four pharma stocks will be reacting to important news updates today
CNBC TV18 · 15 d ago
BU
Srirup Sircar Takes New HR Role At Cipla
Businessworld · 16 d ago
EC
Maha FDA Hits Cipla Again with New Cancellation Order
Economic Times · 17 d ago
MI
Tukaram Mundhe in action! Maharashtra FDA cancels Cipla's Pune drug sale licence
Mint · 17 d ago
BU
Vipin Paulose Takes Charge As Cipla Head HR
Businessworld · 18 d ago
BU
Vipin Paulose Takes Charge As Cipla Head HR, Respiratory Cluster
Businessworld · 18 d ago
MI
Linux Laboratories raises $70 mn led by ChrysCapital and Tata Capital
Mint · 20 d ago
CN
Explained: Why Morgan Stanley has the second-lowest price target on the Street for this drugmaker
cnbctv · 46 d ago
MO
Cipla shares slip after Keytruda biosimilar deal with Qilu, as competition worries weigh; Morgan Stanley cautious
moneycontrol · 46 d ago
CN
Cipla announces exclusive US partnership with Qilu Pharma for keytruda biosimilar
cnbctv · 46 d ago
CN
Sun Pharma, Cipla have more upside; Chinese drug deals may lower oncology costs: Systematix
cnbctv · 48 d ago
CN
Cipla shares gain after it inks cancer treatment drug licensing deal with Sino Biopharma arm
cnbctv · 49 d ago
BI
China Biopharma Grants Cipla Exclusive License For TQB2102
binance_news · 49 d ago
CN
Cipla licenses experimental HER2 cancer drug for India, South Africa and five other markets
cnbctv · 49 d ago
End of the feed